Amgen
(NASDAQ:AMGN)
$246.25
At close: Aug 5
$244.92
-1.3300[-0.54%]
PreMarket: 5:18AM EDT
Day High/Low- - -
52 Week High/Low214.39 - 258.45
Open / Close- / -
Float / Outstanding533.6M / 534.2M
Vol / Avg.2.5K / 3.1M
Mkt Cap131.5B
P/E24.31
50d Avg. Price245.5
Div / Yield7.76/3.15%
Payout Ratio71.27
EPS2.69
Total Float533.6M

Amgen (NASDAQ:AMGN), Quotes and News Summary

Amgen (NASDAQ: AMGN)

Day High/Low- - -
52 Week High/Low214.39 - 258.45
Open / Close- / -
Float / Outstanding533.6M / 534.2M
Vol / Avg.2.5K / 3.1M
Mkt Cap131.5B
P/E24.31
50d Avg. Price245.5
Div / Yield7.76/3.15%
Payout Ratio71.27
EPS2.69
Total Float533.6M
Sector: Health Care.Industry: Biotechnology
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Earnings

see more
Q3 2022Est.ActualSurprise
EPS
(EXPECTED)2022-11-01
REV
Q2 2022Est.ActualSurprise
EPS4.4004.650 0.2500
REV6.530B6.594B64.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Amgen Questions & Answers

Q
How do I buy Amgen (AMGN) stock?
A

You can purchase shares of Amgen (NASDAQ: AMGN) through any online brokerage.

View our list of the best stock brokerages.

Q
What is the target price for Amgen (AMGN) stock?
A

The latest price target for Amgen (NASDAQ: AMGN) was reported by RBC Capital on Friday, August 5, 2022. The analyst firm set a price target for 236.00 expecting AMGN to fall to within 12 months (a possible -4.16% downside). 27 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Amgen (AMGN)?
A

The stock price for Amgen (NASDAQ: AMGN) is $246.25 last updated August 5, 2022, 8:00 PM UTC.

Q
Does Amgen (AMGN) pay a dividend?
A

The next Amgen (AMGN) dividend date is projected to be Wednesday, August 17, 2022.

Q
When is Amgen (NASDAQ:AMGN) reporting earnings?
A

Amgen’s Q3 earnings are confirmed for Tuesday, November 1, 2022.

Q
Is Amgen (AMGN) going to split?
A

There is no upcoming split for Amgen.

Q
What sector and industry does Amgen (AMGN) operate in?
A

Amgen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.